Jodie Ouahed1, Judith R Kelsen2, Waldo A Spessott3, Kameron Kooshesh4, Maria L Sanmillan3, Noor Dawany5, Kathleen E Sullivan6, Kathryn E Hamilton2, Voytek Slowik7, Sergey Nejentsev8,9, João Farela Neves10,11, Helena Flores12, Wendy K Chung13, Ashley Wilson13, Kwame Anyane-Yeboa13, Karen Wou13, Preti Jain14,15, Michael Field1, Sophia Tollefson1, Maiah H Dent16, Dalin Li17, Takeo Naito17, Dermot P B McGovern17, Andrew C Kwong1,18,19, Faith Taliaferro1,19, Jose Ordovas-Montanes1,19,20,21, Bruce H Horwitz1,22, Daniel Kotlarz1,23, Christoph Klein23, Jonathan Evans24, Jill Dorsey24, Neil Warner25,26, Abdul Elkadri25,26, Aleixo M Muise25,26, Jeffrey Goldsmith27, Benjamin Thompson28, Karin R Engelhardt28, Andrew J Cant28,29, Sophie Hambleton28,29, Andrew Barclay30, Agnes Toth-Petroczy4,31,32, Dana Vuzman4, Nikkola Carmichael4, Corneliu Bodea4, Christopher A Cassa4, Marcella Devoto33,34,35, Richard L Maas4, Edward M Behrens36, Claudio G Giraudo3, Scott B Snapper1,37. 1. Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Boston Children's Hospital, and Harvard Medical School, Boston, MA, 02115, USA. 2. Division of Gastroenterology, Hepatology, and Nutrition, The Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA. 3. Department of Microbiology and Immunology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, 19107, USA. 4. Brigham Genomic Medicine Program, Division of Genetics, Department of Medicine, Brigham & Women's Hospital and Harvard Medical School, Boston, MA, 02115, USA. 5. Department of Biomedical Health Informatics, The Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA. 6. Division of Allergy and Immunology, The Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA. 7. Department of Medicine, Division of Gastroenterology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA. 8. Division of Gastroenterology, Hepatology, and Nutrition, Children's Mercy Kansas City, Kansas City, MO, 64108, USA. 9. Department of Medicine, University of Cambridge, Cambridge, CB2 0QQ, UK. 10. Department of Molecular Cell Biology and Immunology, Amsterdam University Medical Centers, Amsterdam, the Netherlands. 11. Primary Immunodeficiencies Unit; Hospital Dona Estefânia-CHLC, EPE, Lisbon, 1169, Portugal. 12. CEDOC, Chronic Diseases Research Center, NOVA Medical School, Lisbon, 1150, Portugal. 13. Gastroenterology Unit, Hospital Dona Estefânia-CHLC, EPE, Lisbon, 1169, Portugal. 14. Department of Pediatrics, Columbia University Medical Center, New York, NY, 10032, USA. 15. Department of Medicine, Columbia University Medical Center, New York, NY, 10032, USA. 16. Department of Genetics, Yale University, New Haven, CT, 06510, USA. 17. F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA. 18. Biological and Biomedical Sciences, Harvard Medical School, Boston, MA, 02115, USA. 19. Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA. 20. Program in Immunology, Harvard Medical School, Boston, MA, 02115, USA. 21. Harvard Stem Cell Institute, Cambridge, MA, 02138, USA. 22. Division of Emergency Medicine, Department of Pediatrics, Boston Children's Hospital, and Harvard Medical School, Boston, MA, 02115, USA. 23. Dr. von Hauner Children's Hospital, Department of Pediatrics, University Hospital LMU Munich, Munich, 80337, Germany. 24. Department of Pediatrics, Nemours Children's Specialty Care, Jacksonville, FL 32207, USA. 25. SickKids Inflammatory Bowel Disease Center and Cell Biology Program, Research Institute, Hospital for Sick Children, Toronto, ON, Canada. 26. Department of Pediatrics and Biochemistry, University of Toronto, Hospital for Sick Children, Toronto, ON, M5G 1X8, Canada. 27. Department of Pathology, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA. 28. Primary Immunodeficiency Group, III Theme, Institute of Cellular Medicine, Newcastle University, Newcastle, NE2 4HH, UK. 29. Children's Immunology Service, Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, NE1 4LP, UK. 30. Department of Paediatric Gastroenterology, Royal Hospital for Children, Glasgow, G51 4TF, UK. 31. Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany. 32. Center for Systems Biology Dresden, Dresden, Germany. 33. Division of Human Genetics, The Children's Hospital of Philadelphia, Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. 34. Department of Translational and Precision Medicine, University Sapienza, Rome 00185, Italy. 35. CNR-IRGB, Cagliari 09042, Italy. 36. Division of Rheumatology, The Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA. 37. Division of Gastroenterology, Department of Medicine, Brigham & Women's Hospital and Harvard Medical School, Boston, MA, 02115, USA.
Abstract
BACKGROUND AND AIMS: Very early onset inflammatory bowel disease [VEOIBD] is characterized by intestinal inflammation affecting infants and children less than 6 years of age. To date, over 60 monogenic aetiologies of VEOIBD have been identified, many characterized by highly penetrant recessive or dominant variants in underlying immune and/or epithelial pathways. We sought to identify the genetic cause of VEOIBD in a subset of patients with a unique clinical presentation. METHODS: Whole exome sequencing was performed on five families with ten patients who presented with a similar constellation of symptoms including medically refractory infantile-onset IBD, bilateral sensorineural hearing loss and, in the majority, recurrent infections. Genetic aetiologies of VEOIBD were assessed and Sanger sequencing was performed to confirm novel genetic findings. Western analysis on peripheral blood mononuclear cells and functional studies with epithelial cell lines were employed. RESULTS: In each of the ten patients, we identified damaging heterozygous or biallelic variants in the Syntaxin-Binding Protein 3 gene [STXBP3], a protein known to regulate intracellular vesicular trafficking in the syntaxin-binding protein family of molecules, but not associated to date with either VEOIBD or sensorineural hearing loss. These mutations interfere with either intron splicing or protein stability and lead to reduced STXBP3 protein expression. Knock-down of STXBP3 in CaCo2 cells resulted in defects in cell polarity. CONCLUSION: Overall, we describe a novel genetic syndrome and identify a critical role for STXBP3 in VEOIBD, sensorineural hearing loss and immune dysregulation.
BACKGROUND AND AIMS: Very early onset inflammatory bowel disease [VEOIBD] is characterized by intestinal inflammation affecting infants and children less than 6 years of age. To date, over 60 monogenic aetiologies of VEOIBD have been identified, many characterized by highly penetrant recessive or dominant variants in underlying immune and/or epithelial pathways. We sought to identify the genetic cause of VEOIBD in a subset of patients with a unique clinical presentation. METHODS: Whole exome sequencing was performed on five families with ten patients who presented with a similar constellation of symptoms including medically refractory infantile-onset IBD, bilateral sensorineural hearing loss and, in the majority, recurrent infections. Genetic aetiologies of VEOIBD were assessed and Sanger sequencing was performed to confirm novel genetic findings. Western analysis on peripheral blood mononuclear cells and functional studies with epithelial cell lines were employed. RESULTS: In each of the ten patients, we identified damaging heterozygous or biallelic variants in the Syntaxin-Binding Protein 3 gene [STXBP3], a protein known to regulate intracellular vesicular trafficking in the syntaxin-binding protein family of molecules, but not associated to date with either VEOIBD or sensorineural hearing loss. These mutations interfere with either intron splicing or protein stability and lead to reduced STXBP3 protein expression. Knock-down of STXBP3 in CaCo2 cells resulted in defects in cell polarity. CONCLUSION: Overall, we describe a novel genetic syndrome and identify a critical role for STXBP3 in VEOIBD, sensorineural hearing loss and immune dysregulation.
Authors: Claire Booth; Kimberly C Gilmour; Paul Veys; Andrew R Gennery; Mary A Slatter; Helen Chapel; Paul T Heath; Colin G Steward; Owen Smith; Anna O'Meara; Hilary Kerrigan; Nizar Mahlaoui; Marina Cavazzana-Calvo; Alain Fischer; Despina Moshous; Stephane Blanche; Jana Pachlopnik Schmid; Jana Pachlopnick-Schmid; Sylvain Latour; Genevieve de Saint-Basile; Michael Albert; Gundula Notheis; Nikolaus Rieber; Brigitte Strahm; Henrike Ritterbusch; Arjan Lankester; Nico G Hartwig; Isabelle Meyts; Alessandro Plebani; Annarosa Soresina; Andrea Finocchi; Claudio Pignata; Emilia Cirillo; Sonia Bonanomi; Christina Peters; Krzysztof Kalwak; Srdjan Pasic; Petr Sedlacek; Janez Jazbec; Hirokazu Kanegane; Kim E Nichols; I Celine Hanson; Neena Kapoor; Elie Haddad; Morton Cowan; Sharon Choo; Joanne Smart; Peter D Arkwright; Hubert B Gaspar Journal: Blood Date: 2010-10-06 Impact factor: 22.113
Authors: Aaron McKenna; Matthew Hanna; Eric Banks; Andrey Sivachenko; Kristian Cibulskis; Andrew Kernytsky; Kiran Garimella; David Altshuler; Stacey Gabriel; Mark Daly; Mark A DePristo Journal: Genome Res Date: 2010-07-19 Impact factor: 9.043
Authors: Catherine F Latham; Jamie A Lopez; Shu-Hong Hu; Christine L Gee; Elizabeth Westbury; Duncan H Blair; Chris J Armishaw; Paul F Alewood; Nia J Bryant; David E James; Jennifer L Martin Journal: Traffic Date: 2006-08-10 Impact factor: 6.215
Authors: Anna S Lehle; Henner F Farin; Benjamin Marquardt; Birgitta E Michels; Thomas Magg; Yue Li; Yanshan Liu; Maryam Ghalandary; Katja Lammens; Sebastian Hollizeck; Meino Rohlfs; Fabian Hauck; Raffaele Conca; Christoph Walz; Batia Weiss; Atar Lev; Amos J Simon; Olaf Groß; Moritz M Gaidt; Veit Hornung; Hans Clevers; Nadine Yazbeck; Rima Hanna-Wakim; Dror S Shouval; Neil Warner; Raz Somech; Aleixo M Muise; Scott B Snapper; Philip Bufler; Sibylle Koletzko; Christoph Klein; Daniel Kotlarz Journal: Gastroenterology Date: 2018-09-26 Impact factor: 22.682
Authors: Melvin B Heyman; Barbara S Kirschner; Benjamin D Gold; George Ferry; Robert Baldassano; Stanley A Cohen; Harland S Winter; Patricia Fain; Chris King; Terry Smith; Hashem B El-Serag Journal: J Pediatr Date: 2005-01 Impact factor: 4.406
Authors: Daniel J B Marks; Kana Miyagi; Farooq Z Rahman; Marco Novelli; Stuart L Bloom; Anthony W Segal Journal: Am J Gastroenterol Date: 2009-01 Impact factor: 10.864
Authors: Holm H Uhlig; Tobias Schwerd; Sibylle Koletzko; Neil Shah; Jochen Kammermeier; Abdul Elkadri; Jodie Ouahed; David C Wilson; Simon P Travis; Dan Turner; Christoph Klein; Scott B Snapper; Aleixo M Muise Journal: Gastroenterology Date: 2014-07-21 Impact factor: 33.883
Authors: Scott W Canna; Adriana A de Jesus; Sushanth Gouni; Stephen R Brooks; Bernadette Marrero; Yin Liu; Michael A DiMattia; Kristien J M Zaal; Gina A Montealegre Sanchez; Hanna Kim; Dawn Chapelle; Nicole Plass; Yan Huang; Alejandro V Villarino; Angelique Biancotto; Thomas A Fleisher; Joseph A Duncan; John J O'Shea; Susanne Benseler; Alexei Grom; Zuoming Deng; Ronald M Laxer; Raphaela Goldbach-Mansky Journal: Nat Genet Date: 2014-09-14 Impact factor: 38.330
Authors: Lauren V Collen; David Y Kim; Michael Field; Ibeawuchi Okoroafor; Gwen Saccocia; Sydney Driscoll Whitcomb; Julia Green; Michelle Dao Dong; Jared Barends; Bridget Carey; Madison E Weatherly; Shira Rockowitz; Piotr Sliz; Enju Liu; Alal Eran; Leslie Grushkin-Lerner; Athos Bousvaros; Aleixo M Muise; Christoph Klein; Vanessa Mitsialis; Jodie Ouahed; Scott B Snapper Journal: J Crohns Colitis Date: 2022-09-08 Impact factor: 10.020